메뉴 건너뛰기




Volumn 6, Issue 7, 2011, Pages 1714-1721

Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE;

EID: 79960323555     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11291210     Document Type: Article
Times cited : (102)

References (41)
  • 1
    • 0344791653 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease
    • Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999
    • (1999) J Am Soc Nephrol , vol.10 , pp. 594-600
    • Kielstein, J.T.1    Boger, R.H.2    Bode-Boger, S.M.3    Schaffer, J.4    Barbey, M.5    Koch, K.M.6    Frolich, J.C.7
  • 3
  • 6
    • 77956407839 scopus 로고    scopus 로고
    • Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in predialysis patients with chronic kidney disease
    • Shi B, Ni Z, Zhou W, Yu Z, Gu L, Mou S, Fang W, Wang Q, Cao L, Yan Y, Qian J: Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in predialysis patients with chronic kidney disease. Eur J Intern Med 21: 444-448, 2010
    • (2010) Eur J Intern Med , vol.21 , pp. 444-448
    • Shi, B.1    Ni, Z.2    Zhou, W.3    Yu, Z.4    Gu, L.5    Mou, S.6    Fang, W.7    Wang, Q.8    Cao, L.9    Yan, Y.10    Qian, J.11
  • 8
    • 28444435118 scopus 로고    scopus 로고
    • Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach
    • Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C: Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J Am Soc Nephrol 16: 2449-2455, 2005
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2449-2455
    • Ravani, P.1    Tripepi, G.2    Malberti, F.3    Testa, S.4    Mallamaci, F.5    Zoccali, C.6
  • 9
    • 27444444747 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study
    • Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E: Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol 16: 2456-2461, 2005
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2456-2461
    • Fliser, D.1    Kronenberg, F.2    Kielstein, J.T.3    Morath, C.4    Bode-Boger, S.M.5    Haller, H.6    Ritz, E.7
  • 10
    • 77955904372 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease
    • Wilson AM, Shin DS, Weatherby C, Harada RK, Ng MK, Nair N, Kielstein J, Cooke JP: Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. Vasc Med 15: 267-274, 2010
    • (2010) Vasc Med , vol.15 , pp. 267-274
    • Wilson, A.M.1    Shin, D.S.2    Weatherby, C.3    Harada, R.K.4    Ng, M.K.5    Nair, N.6    Kielstein, J.7    Cooke, J.P.8
  • 11
    • 77952430963 scopus 로고    scopus 로고
    • Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
    • Cavusoglu E, Ruwende C, Chopra V, Poludasu S, Yanamadala S, Frishman WH, Eng C, Pinsky DJ, Marmur JD: Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 210: 226-231, 2010
    • (2010) Atherosclerosis , vol.210 , pp. 226-231
    • Cavusoglu, E.1    Ruwende, C.2    Chopra, V.3    Poludasu, S.4    Yanamadala, S.5    Frishman, W.H.6    Eng, C.7    Pinsky, D.J.8    Marmur, J.D.9
  • 12
    • 70350057304 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality: An update on patient populations with a wide range of cardiovascular risk
    • Bö ger RH, Maas R, Schulze F, Schwedhelm E: Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality: An update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60: 481-487, 2009
    • (2009) Pharmacol Res , vol.60 , pp. 481-487
    • Bö ger, R.H.1    Maas, R.2    Schulze, F.3    Schwedhelm, E.4
  • 15
    • 56249115245 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine: A novel marker of risk and a potential target for therapy in chronic kidney disease
    • Kielstein JT, Zoccali C: Asymmetric dimethylarginine: A novel marker of risk and a potential target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 17: 609-615, 2008
    • (2008) Curr Opin Nephrol Hypertens , vol.17 , pp. 609-615
    • Kielstein, J.T.1    Zoccali, C.2
  • 17
    • 0036156916 scopus 로고    scopus 로고
    • CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease
    • Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Bö ger R: CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13: 490-496, 2002
    • (2002) J Am Soc Nephrol , vol.13 , pp. 490-496
    • Zoccali, C.1    Benedetto, F.A.2    Maas, R.3    Mallamaci, F.4    Tripepi, G.5    Malatino, L.S.6    Bö ger, R.7
  • 18
    • 0026548912 scopus 로고
    • Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
    • Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992
    • (1992) Lancet , vol.339 , pp. 572-575
    • Vallance, P.1    Leone, A.2    Calver, A.3    Collier, J.4    Moncada, S.5
  • 22
    • 0037256204 scopus 로고    scopus 로고
    • Inflammation and atherosclerosis in end-stage renal disease
    • Zoccali C, Mallamaci F, Tripepi G: Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 21: 29-36, 2003
    • (2003) Blood Purif , vol.21 , pp. 29-36
    • Zoccali, C.1    Mallamaci, F.2    Tripepi, G.3
  • 24
    • 34447120049 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes
    • Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner G: Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care 30: 1834-1839, 2007
    • (2007) Diabetes Care , vol.30 , pp. 1834-1839
    • Krzyzanowska, K.1    Mittermayer, F.2    Wolzt, M.3    Schernthaner, G.4
  • 25
    • 23044456774 scopus 로고    scopus 로고
    • Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD
    • Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C: Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 67: 2330-2337, 2005
    • (2005) Kidney Int , vol.67 , pp. 2330-2337
    • Mallamaci, F.1    Tripepi, G.2    Cutrupi, S.3    Malatino, L.S.4    Zoccali, C.5
  • 26
    • 33750973371 scopus 로고    scopus 로고
    • Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients
    • Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Kato A, Hishida A: Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am J Kidney Dis 48: 797-805, 2006
    • (2006) Am J Kidney Dis , vol.48 , pp. 797-805
    • Kumagai, H.1    Sakurai, M.2    Takita, T.3    Maruyama, Y.4    Uno, S.5    Ikegaya, N.6    Kato, A.7    Hishida, A.8
  • 27
    • 0032935896 scopus 로고    scopus 로고
    • Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
    • Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999
    • (1999) Kidney Int , vol.55 , pp. 648-658
    • Zimmermann, J.1    Herrlinger, S.2    Pruy, A.3    Metzger, T.4    Wanner, C.5
  • 28
    • 0034004568 scopus 로고    scopus 로고
    • C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
    • Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
    • (2000) Am J Kidney Dis , vol.35 , pp. 469-476
    • Yeun, J.Y.1    Levine, R.A.2    Mantadilok, V.3    Kaysen, G.A.4
  • 30
    • 62349126160 scopus 로고    scopus 로고
    • The effect of joint exposures: Examining the presence of interaction
    • de Mutsert R, Jager KJ, Zoccali C, Dekker FW: The effect of joint exposures: examining the presence of interaction. Kidney Int 75: 677-681, 2009
    • (2009) Kidney Int , vol.75 , pp. 677-681
    • de Mutsert, R.1    Jager, K.J.2    Zoccali, C.3    Dekker, F.W.4
  • 32
    • 0347511748 scopus 로고    scopus 로고
    • Novel cardiovascular risk factors in end-stage renal disease
    • Zoccali C, Mallamaci F, Tripepi G: Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 15[Suppl 1]: S77-S80, 2004
    • (2004) J Am Soc Nephrol , vol.15 , Issue.SUPPL. 1
    • Zoccali, C.1    Mallamaci, F.2    Tripepi, G.3
  • 33
    • 54949136493 scopus 로고    scopus 로고
    • Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): Is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
    • Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, Tapan S, Kucukardali Y, Sanisoglu YS, Solmazgul E, Sahan B, Sayan O: Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): Is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35: 2024-2029, 2008
    • (2008) J Rheumatol , vol.35 , pp. 2024-2029
    • Terekeci, H.M.1    Oktenli, C.2    Ozgurtas, T.3    Nalbant, S.4    Top, C.5    Celik, S.6    Tapan, S.7    Kucukardali, Y.8    Sanisoglu, Y.S.9    Solmazgul, E.10    Sahan, B.11    Sayan, O.12
  • 36
    • 36849035846 scopus 로고    scopus 로고
    • The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance
    • Konukoglu D, Firtina S, Serin O: The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism 57: 110-115, 2008
    • (2008) Metabolism , vol.57 , pp. 110-115
    • Konukoglu, D.1    Firtina, S.2    Serin, O.3
  • 37
    • 74049159439 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases
    • Owczarek D, Cibor D, Mach T: Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases. Inflamm Bowel Dis 16: 52-57, 2010
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 52-57
    • Owczarek, D.1    Cibor, D.2    Mach, T.3
  • 38
    • 40149096187 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C
    • Zhang GG, Bai YP, Chen MF, Shi RZ, Jiang DJ, Fu QM, Tan GS, Li YJ: Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. Vascul Pharmacol 48: 115-121, 2008
    • (2008) Vascul Pharmacol , vol.48 , pp. 115-121
    • Zhang, G.G.1    Bai, Y.P.2    Chen, M.F.3    Shi, R.Z.4    Jiang, D.J.5    Fu, Q.M.6    Tan, G.S.7    Li, Y.J.8
  • 41
    • 3142606890 scopus 로고    scopus 로고
    • Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia
    • Lu TM, Ding YA, Leu HB, Yin WH, Sheu WH, Chu KM: Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Am J Cardiol 94: 157-161, 2004
    • (2004) Am J Cardiol , vol.94 , pp. 157-161
    • Lu, T.M.1    Ding, Y.A.2    Leu, H.B.3    Yin, W.H.4    Sheu, W.H.5    Chu, K.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.